Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy

MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA and FARKHAD MANAPOV
Anticancer Research April 2020, 40 (4) 2319-2322; DOI: https://doi.org/10.21873/anticanres.14198
MICHAEL HOFFMANN
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Michael.hoffmann{at}med.uni-muenchen.de
DANIEL REITZ
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JULIAN TAUGNER
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OLARN ROENGVORAPHOJ
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LUKAS KÄSMANN
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
2Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany
3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHUKWUKA EZE
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MONIKA KARIN
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CLAUS BELKA
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
2Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany
3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FARKHAD MANAPOV
1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
2Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany
3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 40, Issue 4
April 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy
MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA, FARKHAD MANAPOV
Anticancer Research Apr 2020, 40 (4) 2319-2322; DOI: 10.21873/anticanres.14198

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy
MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA, FARKHAD MANAPOV
Anticancer Research Apr 2020, 40 (4) 2319-2322; DOI: 10.21873/anticanres.14198
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Antiemetic Efficacy of Aprepitant in Cisplatin–Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter Study
  • Prognostic and Neurological Outcomes Following Surgery for Spinal NF2-Associated Ependymomas With Cysts
  • Prior Chlamydia trachomatis Infection and the Risk of Epithelial Ovarian Cancer and Borderline Ovarian Tumors
Show more Clinical Studies

Keywords

  • NSCLC
  • chemoradiotherapy
  • survival
  • prognostic factor
  • blood parameters
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire